[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.191.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

January 2020 - January 1925

Decade

Year

Issue

December 2019, Vol 145, No. 12, Pages 1097-1179

In This Issue of JAMA Otolaryngology

Highlights

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1097. doi:10.1001/jamaoto.2018.2813
Viewpoint

The 2019 AHNS Annual Meeting Presidential Address—The Future of AHNS in a Competitive Environment

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1101-1102. doi:10.1001/jamaoto.2019.2850

In this Viewpoint, Ehab Hanna, MD, president of the American Head and Neck Society, gives the 2019 annual meeting address.

Prolonging Life, but at What Price?

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1103-1104. doi:10.1001/jamaoto.2019.2855

This Viewpoint describes quality of life and other factors that should be considered when elderly patients make cancer treatment decisions.

Original Investigation

Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus–Associated Oropharyngeal Cancer

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1105-1114. doi:10.1001/jamaoto.2019.0820

This retrospective cohort study assesses the performance of the traditional pathologic risk stratification system for surgically resected human papillomavirus–associated oropharyngeal squamous cell carcinoma and proposes an alternate composite risk stratification system.

Development and Assessment of a Machine Learning Model to Help Predict Survival Among Patients With Oral Squamous Cell Carcinoma

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1115-1120. doi:10.1001/jamaoto.2019.0981

This cohort study describes a model using machine learning to help predict 5-year overall survival among patients with oral squamous cell carcinoma (OSCC) and compares this model with a prediction model created from the TNM (Tumor, Node, Metastasis) clinical and pathologic stage.

Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors

Abstract Full Text
has active quiz
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1121-1127. doi:10.1001/jamaoto.2019.1012

This study uses Veterans Affairs Corporate Data Warehouse data to examine whether there is an association between prior hematologic malignant tumor and risk of head and neck cancer and assesses the overall survival among these patients.

Association of Preoperative Functional Performance With Outcomes After Surgical Treatment of Head and Neck Cancer: A Clinical Severity Staging System

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1128-1136. doi:10.1001/jamaoto.2019.1035

This cohort study evaluates the association of the addition of adult patients’ functional performance to other important preoperative clinical characteristics with 30-day and 90-day hospital readmissions and overall survival after surgical treatment of head and neck cancer.

Assessment of Intraoperative Nerve Monitoring Parameters Associated With Facial Nerve Outcome in Parotidectomy for Benign Disease

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1137-1143. doi:10.1001/jamaoto.2019.1041

This case series study analyzes intraoperative facial nerve monitoring data from adult patients who had a parotidectomy operation and identifies the monitoring parameters associated with postoperative nerve weakness.

Socioeconomic and Demographic Variation in Insurance Coverage Among Patients With Head and Neck Cancer After the Affordable Care Act

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1144-1149. doi:10.1001/jamaoto.2019.2724

This cohort study of 131 779 patients with head and neck cancer examines the association of the Patient Protection and Affordable Care Act with insurance status across socioeconomic and demographic subpopulations.

Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1150-1157. doi:10.1001/jamaoto.2019.2768

This cohort study examines factors associated with 30-day postoperative complications, 90-day mortality, and 90-day functional decline and creates a preoperative risk stratification system for elderly patients undergoing head and neck ablation and reconstruction.

Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1160-1167. doi:10.1001/jamaoto.2019.2381

This cohort study uses the SEER-Medicare outcomes and claims database to evaluate the quality, outcomes, and costs associated with radiation therapy with or without cisplatin or cetuximab for older adults with stage III to IVB head and neck cancer.

Evaluation of Older Age and Frailty as Factors Associated With Depression and Postoperative Decision Regret in Patients Undergoing Major Head and Neck Surgery

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1170-1178. doi:10.1001/jamaoto.2019.3020

This cohort study assesses whether age and frailty are associated with preoperative and/or worsening postoperative depression and postoperative decision regret in patients undergoing major head and neck surgery and identifies additional factors associated with depression and decision regret.

Invited Commentary

The Challenges of Operating on the Oldest Old—The Fountain of Youth Continues to Elude Head and Neck Reconstructive Surgeons

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1158-1159. doi:10.1001/jamaoto.2019.2823

Treatment of Head and Neck Cancer—Sometimes, Less Is More

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1167-1169. doi:10.1001/jamaoto.2019.3078

Determining Operative Candidacy and Avoiding Regret

Abstract Full Text
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1178-1179. doi:10.1001/jamaoto.2019.3021
JAMA Otolaryngology–Head & Neck Surgery Masthead

JAMA Otolaryngology–Head & Neck Surgery

Abstract Full Text
free access
JAMA Otolaryngol Head Neck Surg. 2019;145(12):1099. doi:10.1001/jamaoto.2018.2814
×